Tag: quinolones market outlook.

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Quinolones Industry In 2025?

The quinolones market has demonstrated consistent growth in its size over recent years. Its value is projected to increase from $50.05 billion in 2024 to $51.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.7%. This historic expansion can be attributed to elements such as the demand for and usage of antibiotics, various regulatory approvals, ongoing research and development efforts, the prevailing competitive landscape, and patent expirations.

The quinolones market is projected for significant expansion over the coming years, with its size expected to reach $63.17 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period is attributable to several factors, including the emergence of new diseases, shifts in regulatory frameworks, evolving global health policies, an increase in antibiotic resistance, and strategic market expansion initiatives. Key trends expected during this period involve the development of novel products and alterations in the regulatory environment.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Which Industry Drivers Are Expected To Accelerate The Quinolones Market From 2025 To 2029?

An increase in infectious disease cases substantially propels the expansion of the quinolones market. These diseases are health conditions triggered by microorganisms like bacteria, viruses, fungi, and parasites. Quinolones find extensive application in managing various bacterial infectious diseases, including tuberculosis and urinary tract infections. For instance, the Global Tuberculosis Report, published by the Switzerland-based World Health Organization in November 2023, indicated that newly diagnosed global TB cases reached 7.5 million in 2022, an increase from 6.4 million in 2021. Consequently, the growing frequency of infectious diseases is set to propel the quinolones market forward.

What Are The Different Segment Classifications Within The Quinolones Market?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

How Are Emerging Market Trends Shaping The Quinolones Industry Landscape?

Product innovation stands out as a key trend increasing in popularity within the quinolones market. Major companies operating in this sector are focusing on developing innovative products to maintain their market position. For instance, in January 2023, the South Korean branch of Viatris, a pharmaceutical company based in the US, launched Dovprela, a new treatment for drug-resistant tuberculosis. Dovprela is a three-drug regimen composed of bedaquiline, pretomanid, and linezolid (BPaL), designed for treating adult patients with extensively drug-resistant TB and multidrug-resistant TB that is treatment-resistant or non-responsive. This medication reduces the treatment period from 18-20 months to 5-6 months, attributed to its rapid anti-tuberculosis effect.

Which Major Firms Are Strengthening Their Position In The Quinolones Industry?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Regional Markets Are Contributing Most To The Quinolones Industry Expansion?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Quinolones Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

Browse Through More Reports Similar to the Global Quinolones Market 2025, By The Business Research Company

Grain Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-products-global-market-report

Grain Farming Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-farming-global-market-report

Grain Alcohol Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-alcohol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

#What Are The Market Size Estimates For The Quinolones Market?#_x000D_

The size of the quinolones market has exhibited steady growth in the past few years. The market which was valued at $50.05 billion in 2024, is projected to escalate to $51.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.7%. This growth during the historical period can be ascribed to factors such as defied demand and use of antibiotics, regulatory acquiescences, research and development activities, competition in the market, and patent expirations._x000D_

_x000D_

The market size of quinolones is projected to experience robust growth in the coming years, reaching “$63.17 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 5.0%. Factors contributing to this growth during the forecast period include the prevalence of new diseases, alterations in regulation, modifications in global health policies, increased antibiotic resistance, and strategies for market expansion. Notable trends during this time are anticipated to be the development of new products and shifts in the regulatory framework._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp_x000D_

_x000D_

#What Market Forces Are Contributing To The Growth Of The Quinolones Market?#_x000D_

The surge in infectious diseases rates is playing a significant role in the expansion of the quinolones market. These diseases are caused by various microbes, including parasites, fungi, bacteria, and viruses. Quinolones are widely utilized in the treatment of numerous infectious diseases like tuberculosis and urinary tract infections which are bacterial in nature. For example, data from the Global Tuberculosis Report by the World Health Organization, based in Switzerland, indicated a rise in newly diagnosed TB cases, escalating to 7.5 million in 2022 from 6.4 million in 2021. Thus, the increasing occurrence of infectious diseases consequently propels the growth of the quinolones market._x000D_

_x000D_

#What Is The Segment Breakdown Of The Quinolones Market?#_x000D_

The quinolones market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types_x000D_

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen_x000D_

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Norfloxacin: Indications, Dosage Forms _x000D_

2) By Ofloxacin: Indications, Dosage Forms _x000D_

3) By Ciprofloxacin: Indications, Dosage Forms _x000D_

4) By Gemifloxacin: Indications, Dosage Forms _x000D_

5) By Other Types: Various Formulations, Indications_x000D_

_x000D_

#How Are Global Trends Impacting The Development Of The Quinolones Market?#_x000D_

One of the prevailing trends in the quinolones market is product innovation, with major market players striving to create innovative products to maintain their dominance in the market. For instance, Viatris’s South Korean division, a pharmaceutical corporation headquartered in the United States, introduced Dovprela, a ground-breaking drug-resistant TB treatment, in January 2023. Dovprela, a combination of bedaquiline, pretomanid, and linezolid (BPaL), is designed for adults suffering from extensively drug-resistant TB or multidrug-resistant TB that does not respond to treatment. Due to its accelerated anti-tuberculosis action, Dovprela cuts the treatment time from 18-20 months to just 5-6 months._x000D_

_x000D_

#Which Firms Are Driving Innovation Within The Quinolones Market?#_x000D_

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd. _x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report_x000D_

_x000D_

#Which Region Is Likely To Register The Fastest Growth In The Quinolones Market?#_x000D_

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Quinolones Market Heading Into 2029?

The size of the quinolones market has seen a consistent increase in the past few years. The market, valued at $50.05 billion in 2024, is projected to reach $51.89 billion in 2025, growing at a compound annual growth rate (CAGR) of 3.7%. The expansion witnessed in the historic time frame owes to factors like increased demand for and use of antibiotics, regulatory sanctions, extensive research and development, competitive market scenarios, and impending patent expirations.

Anticipated robust expansion is predicted for the quinolones market in the forthcoming years. It’s projected to reach a value of $63.17 billion in 2029, with a compound annual growth rate (CAGR) of 5.0%. Factors contributing to growth during this period include the emergence of new diseases, modifications in regulations, evolution of global health policies, increasing antibiotic resistance, and extensive market growth tactics. Significant trends during the forecast period encompass the development of new products and alterations in the regulatory environment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Which Factors Are Pushing The Quinolones Market Forward?

The quinolones market is experiencing substantial growth due to the increasing prevalence of infectious diseases. These illnesses, caused by microorganisms like parasites, bacteria, viruses, and fungi, often require treatment with quinolones. These drugs are particularly effective for bacterial infections such as tuberculosis and urinary tract infections. Data from the Global Tuberculosis Report by Switzerland’s World Health Organization in November 2023 highlighted an increase in fresh TB diagnoses to 7.5 million in 2022, up from 6.4 million in 2021. As a result, this uptick in infectious diseases cases will act as a driver for the quinolones market.

Which Segment Held The Largest Share In The Quinolones Market In 2025?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

How Are Key Trends Driving Expansion In The Quinolones Industry?

The main trend gaining traction in the quinolones market is product innovation. In order to maintain their market standing, many of the significant companies within the quinolones market are putting a heavy focus on creating innovative products. An example of this is when a new drug-resistant tuberculosis treatment, Dovprela, was introduced by the South Korean branch of Viatris, an American pharmaceutical company, in January 2023. For the treatment of adult patients suffering from extensively drug-resistant TB or non-responsive multidrug-resistant TB, Dovprela uses a three-drug regimen of bedaquiline, pretomanid, and linezolid (BPaL). Due to its potent anti-tuberculosis properties, the drug can cut down the treatment duration from 18-20 months to only 5-6 months.

Which Organizations Are Driving Progress In The Quinolones Industry?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Quinolones Industry?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the quinolones industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Quinolones Market Through 2034?_x000D_

The size of the quinolones market has been consistently expanding over the past few years. The market is projected to increase from $50.05 billion in 2024 to $52.39 billion in 2025, with a compound annual growth rate (CAGR) of 4.7%. Factors such as demand for antibiotics, regulatory sanctions, research and development initiatives, industry competition, and patent expiry dates have contributed to the growth seen in the historical period._x000D_

_x000D_

Anticipations are high for a robust expansion in the quinolones market size in the years to come. It’s projected to rise to a staggering $64.61 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. This predicted growth in the upcoming period can be attributed to several factors such as the emergence of new diseases, alterations in regulations, international health policies, an increase in antibiotic resistance, and strategies for market proliferation. The period under forecast promises significant trends like the introduction of new products and transformations in the regulatory framework._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp_x000D_

_x000D_

#How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Quinolones Market?#_x000D_

The quinolones market is experiencing remarkable growth largely due to the increasing prevalence of infectious diseases. These diseases are typically triggered by various microorganisms, including parasites, fungi, bacteria, and viruses. Quinolones are often employed to combat a host of bacterial infectious diseases, such as tuberculosis and urinary tract infections. For example, the World Health Organization, based in Switzerland, revealed in the Global Tuberculosis Report in November 2023 that there was an uptick in the number of newly identified TB cases worldwide, going from 6.4 million in 2021 to 7.5 million in 2022. This escalating incidence of infectious diseases is a key factor propelling the quinolones market forward._x000D_

_x000D_

#Which Segments in the Quinolones Offer the Most Growth?#_x000D_

The quinolones market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types_x000D_

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen_x000D_

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Norfloxacin: Indications, Dosage Forms_x000D_

2) By Ofloxacin: Indications, Dosage Forms_x000D_

3) By Ciprofloxacin: Indications, Dosage Forms_x000D_

4) By Gemifloxacin: Indications, Dosage Forms_x000D_

5) By Other Types: Various Formulations, Indications_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the Quinolones Market?#_x000D_

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Current Market Growth and Trends in the Quinolones Industry?#_x000D_

The primary trend that’s gaining traction in the quinolones market is product innovation. Major players in the quinolones industry are concentrating their efforts on creating innovative products to maintain their hold in the market. For example, Viatris, a US-based pharmaceutical firm’s South Korean division introduced a novel drug-resistant tuberculosis treatment, Dovprela, in January 2023. This unique three-drug combination of bedaquiline, pretomanid, and linezolid (BPaL) aims to treat adult patients suffering from extensively drug-resistant TB and those resistant or non-responsive to multidrug-resistant TB therapy. With its fast-acting anti-tuberculosis properties, Dovprela reduces the treatment duration from 18-20 months down to 5-6 months._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Quinolones Market?#_x000D_

Quinolones refer to bactericidal antibiotics that directly kill bacteria cells of both gram-positive and gram-negative types. Quinolones are used to treat various infectious diseases caused by bacteria._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9429_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theQuinolones Market?

The quinolones market is experiencing substantial growth due to the increasing prevalence of infectious diseases. Infectious diseases are caused by microbes, including parasites, fungi, bacteria, and viruses. Quinolones are frequently used in the treatment of various bacterial-caused infectious diseases, such as tuberculosis and urinary tract infections. According to the Global Tuberculosis Report by the World Health Organization, a health agency based in Switzerland, there were 7.5 million new TB cases globally in 2022, up from 6.4 million in 2021. Therefore, the growing number of infectious diseases is contributing to the expansion of the quinolones market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

What is the Predicted Annual Growth Rate of theQuinolones Market Impact Industry Trends by 2034?

In recent times, the quinolones market size has been undergoing steady expansion. From a market value of $50.05 billion in 2024, it is projected to climb to $52.39 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.7%. The escalation observed in the historic phase can be linked to factors such as the requirement and usage of antibiotics, endorsements from regulatory bodies, research and development activities, competitive market dynamics, and the expiration of patents.

The size of the quinolones market is anticipated to experience significant expansion in the upcoming years. It is projected to reach a valuation of $64.61 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.4%. This projected growth during the forecast period can be linked to factors such as the emergence of new diseases, regulatory shifts, changes in global health policies, the increase in antibiotic resistance, and market development strategies. Key trends during this forecast period include the development of new products, and transformations in the regulatory environment.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9429

What Are the Current Market Growth and Trends in theQuinolones Market That Industry Players Should Watch?

Innovation in product creation is the principal trend that’s becoming famous in the quinolones market. Firms at the forefront of the quinolones market are prioritizing the development of groundbreaking products to maintain their market dominance. For example, Viatris’ South Korean division, an American pharmaceutical firm, introduced Dovprela, a novel treatment for drug-resistant tuberculosis, in January 2023. Dovprela is a mixture of three drugs: bedaquiline, pretomanid, and linezolid (BPaL), designed to treat adult patients plagued with hard-to-treat TB and resistant or non-responsive multidrug-resistant TB. Dovprela, thanks to its swift anti-tuberculosis effect, slashes the typical treatment duration from 18-20 months down to just 5-6 months.

What Are the Major Market Players Making an Impact on theQuinolones Market Growth?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

How Are the Key Segments of the Quinolones Market Driving Opportunities and Innovations?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theQuinolones Market?# Market Expansion?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Quinolones Maret 2025, By The Business Research Company:

Feed Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/feed-processing-equipment-global-market-report

Grain Alcohol Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/grain-alcohol-global-market-report

Dairy Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dairy-processing-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the quinolones market size evolved in recent years?

The size of the quinolones market has seen consistent growth in the past few years. It is projected to expand from $50.05 billion in 2024 to $52.39 billion in 2025, showing a compound annual growth rate (CAGR) of 4.7%. Factors contributing to this growth during the historical period include demand and use of antibiotics, regulatory approvals, research and development initiatives, the competitive environment, and patent expirations.

What are the predictions for the quinolones market size in the coming years?

The market size of quinolones is anticipated to witness a robust expansion in the coming years. A considerable surge to $64.61 billion is projected by the year 2029, with a Compound Annual Growth Rate (CAGR) of 5.4%. This growth during the prediction period can be credited to factors such as the rise of unfamiliar diseases, modifications in regulations, alterations in global health policies, increased resistance to antibiotics, and strategic approaches to enlarging the market. Key trends within the forecast period entail the development of new products, and transformations in regulatory frameworks.

Get your quinolones market report here!

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

What key factors are fueling the growth of the quinolones market?

The escalation of infectious disease occurrences substantially contributes to the expansion of the quinolones market. Such diseases, caused by microbes such as parasites, fungi, bacteria, and viruses, are commonly treated with quinolones, particularly those bacterial infections like tuberculosis and urinary tract infections. For instance, the Switzerland-based World Health Organization’s Global Tuberculosis Report from November 2023 revealed that there was an increase in newly diagnosed TB cases worldwide from 6.4 million in 2021 to 7.5 million in 2022. Consequently, the surge in the prevalence of infectious diseases propels the quinolones market’s growth.

How is the global quinolones market divided into key segments?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Who are the key firms paving the way for growth in the quinolones market?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Which trends are expected to transform the quinolones market?

The dominant trend emerging within the quinolones market is product innovation. Industry leaders are focusing their efforts on creating novel products to solidify their market stance. To illustrate, in January 2023, Viatris’s South Korean division, a pharmaceutical corporation based out of the US, introduced Dovprela to the market, a revolutionary treatment for drug-resistant tuberculosis. Dovprela operates as a three-drug regimen consisting of bedaquiline, pretomanid, and linezolid (BPaL), designed to treat adult patients suffering from extensively drug-resistant TB or non-responsive-multidrug resistant TB. It drastically decreases the treatment duration from 18-20 months to a mere 5-6 months, thanks to its swift anti-tuberculosis action.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9429

What regions are contributing significantly to the growth of the quinolones market?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Feed Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/feed-processing-equipment-global-market-report

Grain Alcohol Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/grain-alcohol-global-market-report

Dairy Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dairy-processing-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Quinolones Market Achieve During 2025–2034, and What Does It Indicate?

The market size of quinolones has seen constant growth in the past few years. It is projected to rise from $50.05 billion in 2024 to $52.39 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.7%. Factors such as demand and usage of antibiotics, regulatory validation, research and development, competition in the market, and patent terminations have contributed to this growth during the historical period.

The market for quinolones is predicted to experience significant expansion in the forthcoming years, with an expected value of $64.61 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.4%. The surge during the forecast period could be due to the onset of novel diseases, modifications in regulations, adjustments in global health policies, increased antibiotic resistance, and strategies for expanding the market. Key trends anticipated in the forecast period encompass the introduction of new products and alterations in the regulatory scenario.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the quinolones Market?

The escalation in the number of infectious disease cases is playing a considerable role in enhancing the quinolones market growth. Microorganisms like parasites, fungi, bacteria, and viruses cause these infectious diseases. Quinolones are extensively employed in the treatment of various bacterial-induced infectious diseases, such as tuberculosis and urinary tract infections. For example, as per the Global Tuberculosis Report released by the World Health Organization, a Switzerland-based health entity, in November 2023, the total number of newly detected TB cases worldwide rose to 7.5 million in 2022, seeing an upturn from 6.4 million in 2021. Thus, the growth in the occurrence of infectious diseases is a key driver for the quinolones market.

Request Your Free Quinolones Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Who Are the Key Firms Paving the Way for Growth in the Quinolones Market?

Major companies operating in the quinolones market include:

• Bayer AG_x000D_

• Novartis AG_x000D_

• Sanofi SA_x000D_

• Merck & Co. Inc._x000D_

• LG Life Sciences_x000D_

What Are the Most Influential Trends Currently Shaping the Quinolones Market?

Product innovation is becoming a major trend in the quinolones market. Many of the leading companies in this sector are prioritizing the creation of innovative products to maintain their market standing. For instance, in January 2023, Viatris’ South Korean division, a pharmaceutical company based in the US, introduced Dovprela, a novel drug-resistant tuberculosis medication. This treatment is a combination of bedaquiline, pretomanid, and linezolid (BPaL) intended for adult patients suffering from extensively drug-resistant TB and those with treatment-resistant or non-responding multidrug-resistant TB. With its potent anti-tuberculosis effect, Dovprela significantly shortens the treatment duration from 18-20 months down to just 5-6 months.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

How Are Market Segments in the Quinolones Industry Positioned for Long-Term Growth?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

Which Regions Are Essential for the Growth of the Quinolones Market?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Scope and Reach of the Quinolones Market Defined?

Quinolones refer to bactericidal antibiotics that directly kill bacteria cells of both gram-positive and gram-negative types. Quinolones are used to treat various infectious diseases caused by bacteria.

Browse Through More Similar Reports By The Business Research Company:

Feed Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/feed-processing-equipment-global-market-report

Grain Alcohol Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/grain-alcohol-global-market-report

Dairy Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dairy-processing-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: